- Published on
Toxicology – Tramadol
Description
Tramadol is a synthetic analgesic with opioid agonist properties.
Forms and Uses
Tramadol, historically marketed as Ultram, is used for pain relief.
Its analgesic action resembles that of opioid medications, although its direct opioid-receptor activity is weaker than that of many traditional opioids.
A typical adult dose is 50–100 mg, administered by various routes including oral, subcutaneous, intramuscular, rectal, or intravenous routes.
Toxic Dose
The toxic dose of tramadol is not precisely established.
Large ingestions are required for severe poisoning, and ingestion of several grams has been associated with fatal outcomes in adults.
Pathophysiology
Tramadol has several pharmacologic actions.
In addition to opioid activity, it inhibits the reuptake of:
Norepinephrine
and
Serotonin
These actions contribute to its analgesic effects but may also contribute to toxicity.
Severe poisoning may result in:
CNS depression + respiratory depression + hypotension
Epidemiology
Tramadol poisoning is relatively uncommon.
Causes
Exposure may be accidental or intentional.
In very young children, inappropriate exposure may raise concern for neglect or abuse.
In older children, adolescents, and adults, intentional overdose should be considered when the clinical circumstances suggest self-harm.
Drug and Disease Interactions
Other medications or substances that depress the central nervous system can produce additive CNS and respiratory depression when combined with tramadol.
Examples include other sedative or opioid substances.
Pregnancy and Lactation
The historical FDA classification listed tramadol as Pregnancy Category C.
Animal studies demonstrated adverse fetal effects, while adequate controlled human studies were unavailable.
Tramadol is excreted into breast milk in small amounts, historically estimated at approximately 0.1% of the maternal dose.
Differential Diagnosis
Other toxic causes of CNS depression include:
Opioids, benzodiazepines, barbiturates, ethanol, baclofen, and gamma-hydroxybutyrate.
Non-toxicologic causes include:
Head trauma, CNS infection, hypoglycemia, hypoxia, and electrolyte or other metabolic disturbances.
Clinical Features
The main manifestations of overdose are related to CNS and respiratory depression.
Patients may also develop gastrointestinal, cardiovascular, neurologic, or musculoskeletal complications.
Vital Signs
Tachycardia and hypertension may occur, although these findings are uncommon.
HEENT
Miosis may occur after acute overdose.
Cardiovascular Effects
Large overdoses may cause:
Hypotension
and, rarely:
Myocardial ischemia
Pulmonary Effects
Respiratory depression is an important manifestation of tramadol overdose.
Rarely, pulmonary edema may develop.
Gastrointestinal Effects
Nausea and vomiting are common.
Renal and Genitourinary Effects
Urinary retention may occur during overdose.
Musculoskeletal Effects
Hypertonia may develop.
Rhabdomyolysis can occur, particularly in severe poisoning.
Neurologic Effects
CNS depression is common after significant overdose.
Patients may become:
Drowsy, confused, obtunded, or unconscious.
Seizures may also occur, although the original description characterizes them as relatively uncommon.
Laboratory Evaluation
Minimally symptomatic patients may not require extensive laboratory testing.
In patients with altered mental status, useful studies include:
Serum electrolytes
Glucose
BUN and creatinine
Creatine kinase
and monitoring of oxygenation.
Pulse Oximetry
Pulse oximetry should be used in patients with significant CNS or respiratory depression.
ECG
An ECG may be obtained in significant overdose, particularly when the ingestion history is uncertain or cardiovascular abnormalities are present.
Screening for Coingestants
In deliberate or uncertain overdose, acetaminophen and salicylate concentrations may be obtained to identify an occult coingestion.
Additional Neurologic Evaluation
When CNS depression cannot be fully explained by tramadol exposure, further investigation may include:
Head CT
Lumbar puncture
Toxicology testing
or other studies directed by the clinical presentation.
Treatment
The general management of tramadol toxicity resembles that of other opioid poisonings.
The priorities are:
Airway protection + respiratory support + circulation support
The amount taken, timing of ingestion, and possible coingestants should be determined whenever possible.
When to Seek Toxicology Assistance
Poison-center or toxicology consultation is appropriate when:
Severe or persistent toxicity develops
or when:
A coingestant, drug interaction, or underlying medical condition complicates management.
Referral to a Health-Care Facility
Medical evaluation is appropriate when:
Symptoms develop
Intentional overdose is suspected
The history is unreliable
or
Important coingestants or medical conditions are present.
Admission
Hospital admission is appropriate for patients with:
CNS depression
Hypotension
or
Respiratory depression
Decontamination – Out of Hospital
Vomiting should not be induced.
Decontamination – In Hospital
The historical management approach included gastric lavage after a large recent ingestion or severe poisoning.
A single dose of activated charcoal was also recommended after a substantial recent ingestion.
Airway protection is particularly important because tramadol can cause CNS depression and seizures.
Antidote
Naloxone is the opioid antagonist used for tramadol-associated opioid toxicity.
The historical regimen described:
Naloxone 2 mg IV initially
If there was no response:
Increase to 4 mg IV
If there was still no response after further escalation, additional naloxone was considered unlikely to provide benefit.
Supportive Care
Even when naloxone is given, supportive care remains essential.
Patients with inadequate ventilation may require:
Supplemental oxygen
Bag-mask ventilation
or
Endotracheal intubation with mechanical ventilation
depending on severity.
Seizures
If seizures occur, they require prompt treatment while airway and respiratory status are monitored closely.
Patient Monitoring
Symptomatic patients should have continuous monitoring of:
Respiratory function
and
Cardiac function
Respiratory Monitoring
Patients with respiratory depression may require:
Arterial blood-gas assessment
and
Pulse oximetry
to evaluate oxygenation and ventilation.
Observation
The original guidance recommends approximately 6 hours of observation after treatment to monitor for recurrent or delayed symptoms.
Expected Course and Prognosis
With adequate supportive care, most patients recover from tramadol overdose without significant long-term complications.
The major immediate threats are:
Respiratory depression
CNS depression
Hypotension
and, in some patients:
Seizures
Discharge From the Emergency Department
An asymptomatic patient may be considered for discharge after an adequate period of observation, historically approximately 6 hours, provided that:
No toxic effects develop
and
Appropriate psychiatric assessment has been completed when indicated.
Discharge From Hospital
Hospitalized patients may be discharged when:
Clinical toxicity has resolved
and they have remained stable without requiring naloxone for an adequate period.
The original text suggests approximately 6 hours without further naloxone requirement.
Important Pitfalls
Do not assume that all CNS depression in a patient who has taken tramadol is caused by tramadol alone.
Other serious causes should be considered, including:
Coingested sedatives or opioids
Head trauma
Infection
Hypoglycemia
Hypoxia
and other metabolic disturbances.
High-Yield Toxicology Pearls
Tramadol is a synthetic analgesic with both opioid and monoaminergic activity.
Its main toxic effects include:
CNS depression + respiratory depression + nausea/vomiting + hypotension ± seizures
Tramadol also inhibits:
Serotonin reuptake
and
Norepinephrine reuptake.
Miosis may occur after acute overdose.
Significant respiratory depression requires:
Airway support + oxygenation/ventilation
Naloxone can reverse the opioid component of tramadol toxicity.
There is no reliably defined toxic dose, although ingestion of several grams has been associated with fatal poisoning in adults.
In significant overdose, monitor:
Mental status
Respiratory function
Cardiac function
and appropriate laboratory studies.
The most important diagnostic warning is:
Do not attribute unexplained CNS depression solely to tramadol until other toxicologic, neurologic, and metabolic causes have been considered.